Australian Broker Call
Produced and copyrighted by at www.fnarena.com
December 18, 2018
Access Broker Call Report Archives here
COMPANIES DISCUSSED IN THIS ISSUE
Click on symbol for fast access.
The number next to the symbol represents the number of brokers covering it for this report -(if more than 1).
Last Updated: 05:00 PM
Your daily news report on the latest recommendation, valuation, forecast and opinion changes.
This report includes concise but limited reviews of research recently published by Stockbrokers, which should be considered as information concerning likely market behaviour rather than advice on the securities mentioned. Do not act on the contents of this Report without first reading the important information included at the end.
For more info about the different terms used by stockbrokers, as well as the different methodologies behind similar sounding ratings, download our guide HERE
Today's Upgrades and Downgrades
APA - | APA | Downgrade to Underperform from Outperform | Credit Suisse |
SIG - | SIGMA HEALTHCARE | Upgrade to Neutral from Sell | UBS |
Credit Suisse rates APA as Downgrade to Underperform from Outperform (5) -
Following confirmation from the Foreign Investment Review Board that the CKI bid will not proceed, Credit Suisse downgrades to Underperform from Outperform.
Another takeover bid remains a key risk but the broker believes this recedes with every passing week and a difficult outlook remains.
The broker adjusts carrying values and increases estimates for the weighted average cost of capital, in line with government bond yields. Target is reduced to $7.65 from $11.00.
Target price is $7.65 Current Price is $8.70 Difference: minus $1.05 (current price is over target).
If APA meets the Credit Suisse target it will return approximately minus 12% (excluding dividends, fees and charges - negative figures indicate an expected loss).
Current consensus price target is $9.50, suggesting upside of 9.2% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY19:
Credit Suisse forecasts a full year FY19 dividend of 46.50 cents and EPS of 23.89 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 25.2, implying annual growth of 8.2%. Current consensus DPS estimate is 47.0, implying a prospective dividend yield of 5.4%. Current consensus EPS estimate suggests the PER is 34.5. |
Forecast for FY20:
Credit Suisse forecasts a full year FY20 dividend of 49.50 cents and EPS of 28.36 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 28.8, implying annual growth of 14.3%. Current consensus DPS estimate is 49.7, implying a prospective dividend yield of 5.7%. Current consensus EPS estimate suggests the PER is 30.2. |
Market Sentiment: 0.1
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
ASB AUSTAL LIMITED
Commercial Services & Supplies
More Research Tools In Stock Analysis - click HERE
Overnight Price: $1.95
Ord Minnett rates ASB as Accumulate (2) -
Austal has been awarded a contract to construct two additional littoral combat ships by the US Navy. Ord Minnett notes Lockheed Martin has not been awarded any vessels in the latest announcement.
The broker considers this latest contract is positive as it will extend the known construction pipeline to 2025. The exact amount of the contract has not been disclosed.
Ord Minnett maintains an Accumulate rating and $2.10 target.
This stock is not covered in-house by Ord Minnett. Instead, the broker whitelabels research by JP Morgan.
Target price is $2.10 Current Price is $1.95 Difference: $0.15
If ASB meets the Ord Minnett target it will return approximately 8% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY19:
Ord Minnett forecasts a full year FY19 dividend of 6.00 cents and EPS of 12.00 cents. |
Forecast for FY20:
Ord Minnett forecasts a full year FY20 dividend of 6.00 cents and EPS of 13.00 cents. |
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Macquarie rates BHP as Outperform (1) -
BHP has received strong demand for its US$5.2bn off-market buyback, scaling back demand by 58.7%. The special dividend is priced at US$1.02, in line with expectations.
Macquarie believes BHP could return an additional US$3.0bn in cash to shareholders during the second half of FY19, most likely through an on market UK buyback.
Outperform maintained. Target is steady at $40.
Target price is $40.00 Current Price is $33.57 Difference: $6.43
If BHP meets the Macquarie target it will return approximately 19% (excluding dividends, fees and charges).
Current consensus price target is $36.88, suggesting upside of 9.9% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY19:
Macquarie forecasts a full year FY19 dividend of 310.54 cents and EPS of 249.77 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 264.8, implying annual growth of N/A. Current consensus DPS estimate is 247.6, implying a prospective dividend yield of 7.4%. Current consensus EPS estimate suggests the PER is 12.7. |
Forecast for FY20:
Macquarie forecasts a full year FY20 dividend of 161.27 cents and EPS of 228.98 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 252.2, implying annual growth of -4.8%. Current consensus DPS estimate is 171.9, implying a prospective dividend yield of 5.1%. Current consensus EPS estimate suggests the PER is 13.3. |
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.6
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
UBS rates BHP as Buy (1) -
BHP has confirmed the return of US$10.4bn in proceeds from the sale of its US onshore business. A US$1.02 fully franked special dividend will be paid to shareholders registered as of January 11, 2019.
The impact on numbers is minimal and UBS maintains a Buy rating and $35 target.
Target price is $35.00 Current Price is $33.57 Difference: $1.43
If BHP meets the UBS target it will return approximately 4% (excluding dividends, fees and charges).
Current consensus price target is $36.88, suggesting upside of 9.9% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY19:
UBS forecasts a full year FY19 dividend of 313.21 cents and EPS of 257.23 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 264.8, implying annual growth of N/A. Current consensus DPS estimate is 247.6, implying a prospective dividend yield of 7.4%. Current consensus EPS estimate suggests the PER is 12.7. |
Forecast for FY20:
UBS forecasts a full year FY20 dividend of 202.59 cents and EPS of 290.55 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 252.2, implying annual growth of -4.8%. Current consensus DPS estimate is 171.9, implying a prospective dividend yield of 5.1%. Current consensus EPS estimate suggests the PER is 13.3. |
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.6
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
CAR CARSALES.COM LIMITED
Automobiles & Components
More Research Tools In Stock Analysis - click HERE
Overnight Price: $11.55
Ord Minnett rates CAR as No Rating (-1) -
Carsales.com has announced a $48m impairment against the carrying value of its 50.1% investment in Stratton. The contribution to net profit is now expected to be around $1m, which Ord Minnett calculates implies a -1% downgrade to FY19 estimates.
The remainder of the business is in line with prior guidance of moderate growth in FY19. Ord Minnett notes the car finance industry has been struggling following greater regulatory scrutiny and Stratton has borne the brunt.
Restructuring is underway although the benefits are not expected in FY19. Ord Minnett still believes Carsales.com is good value but places its Buy rating and $14.84 target under review.
Current Price is $11.55. Target price not assessed.
Current consensus price target is $15.31, suggesting upside of 32.6% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY19:
Ord Minnett forecasts a full year FY19 dividend of 47.00 cents and EPS of 57.40 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 58.6, implying annual growth of 8.5%. Current consensus DPS estimate is 47.3, implying a prospective dividend yield of 4.1%. Current consensus EPS estimate suggests the PER is 19.7. |
Forecast for FY20:
Ord Minnett forecasts a full year FY20 dividend of 52.70 cents and EPS of 64.40 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 64.4, implying annual growth of 9.9%. Current consensus DPS estimate is 50.8, implying a prospective dividend yield of 4.4%. Current consensus EPS estimate suggests the PER is 17.9. |
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Credit Suisse rates FAR as Outperform (1) -
FEED has commenced for the SNE phase 1 development, offshore Senegal. Credit Suisse observes there are a lot of hurdles to clear in 2019 and timing risks are to the downside.
The broker believes the reaction to the outcome of the Samos-1 well has been overdone, although the next 18 months will be critical for the joint venture.
Outperform rating and $0.14 target maintained.
Target price is $0.14 Current Price is $0.07 Difference: $0.07
If FAR meets the Credit Suisse target it will return approximately 100% (excluding dividends, fees and charges).
The company's fiscal year ends in December.
Forecast for FY18:
Credit Suisse forecasts a full year FY18 dividend of 0.00 cents and EPS of minus 0.39 cents. |
Forecast for FY19:
Credit Suisse forecasts a full year FY19 dividend of 0.00 cents and EPS of minus 0.39 cents. |
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $4.13
Macquarie rates FMG as Outperform (1) -
The first shipment of high-great West Pilbara fines has left Port Hedland, bound for Hunan Valin Steel in China. While this is an important milestone, Macquarie believes the realised price for the shipment is a more significant catalyst.
Increasing the realised price for its basket of iron ore products is material for the company as a US$5/t increase in average prices translate to a $2/share increase in valuation.
Macquarie notes the correlation between the share price and realised iron ore prices has broken down over the past few months and a return to the historical relationship would imply a share price above $5.00, assuming an unchanged iron ore price.
Macquarie maintains a $5.00 target and Outperform rating.
Target price is $5.00 Current Price is $4.13 Difference: $0.87
If FMG meets the Macquarie target it will return approximately 21% (excluding dividends, fees and charges).
Current consensus price target is $4.75, suggesting upside of 15.1% (ex-dividends)
The company's fiscal year ends in June.
Forecast for FY19:
Macquarie forecasts a full year FY19 dividend of 31.32 cents and EPS of 52.51 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 45.2, implying annual growth of N/A. Current consensus DPS estimate is 32.7, implying a prospective dividend yield of 7.9%. Current consensus EPS estimate suggests the PER is 9.1. |
Forecast for FY20:
Macquarie forecasts a full year FY20 dividend of 30.39 cents and EPS of 43.45 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 40.5, implying annual growth of -10.4%. Current consensus DPS estimate is 31.4, implying a prospective dividend yield of 7.6%. Current consensus EPS estimate suggests the PER is 10.2. |
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.6
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $3.44
UBS rates IPL as Reinstate Coverage with Neutral (3) -
The Asia-Pacific explosives market is key to Incitec pivot, representing over 30% of group operating earnings (EBIT). The outlook for volumes is positive as mining demand normalises, UBS observes.
Nevertheless, despite the overall improvement in the global commodity cycle, the broker believes the Australian ammonium nitrate market has excess capacity relative to demand, and this will weigh for the next few years.
UBS reinstates coverage with a Neutral rating and $3.70 target.
Target price is $3.70 Current Price is $3.44 Difference: $0.26
If IPL meets the UBS target it will return approximately 8% (excluding dividends, fees and charges).
Current consensus price target is $4.14, suggesting upside of 20.2% (ex-dividends)
The company's fiscal year ends in September.
Forecast for FY19:
UBS forecasts a full year FY19 dividend of 13.00 cents and EPS of 26.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 25.3, implying annual growth of 102.4%. Current consensus DPS estimate is 13.2, implying a prospective dividend yield of 3.8%. Current consensus EPS estimate suggests the PER is 13.6. |
Forecast for FY20:
UBS forecasts a full year FY20 dividend of 13.00 cents and EPS of 26.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 25.9, implying annual growth of 2.4%. Current consensus DPS estimate is 13.4, implying a prospective dividend yield of 3.9%. Current consensus EPS estimate suggests the PER is 13.3. |
Market Sentiment: 0.5
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $0.33
Macquarie rates KLL as Outperform (1) -
The company has announced a $2.8m share placement to fund early works at Beyondie, a FEED study and associated development.
Macquarie lowers the assumed price of capital to fund the development, lowering the target to $0.65 from $0.75.
Outperform rating maintained. The broker expects a final investment decision over the first half of 2019.
Target price is $0.65 Current Price is $0.33 Difference: $0.32
If KLL meets the Macquarie target it will return approximately 97% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY19:
Macquarie forecasts a full year FY19 dividend of 0.00 cents and EPS of minus 2.40 cents. |
Forecast for FY20:
Macquarie forecasts a full year FY20 dividend of 0.00 cents and EPS of minus 1.50 cents. |
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $3.33
Ord Minnett rates MWY as Buy (1) -
Midway has upgraded earnings estimates, based on an 11% price increase for its woodchip exports to China. Ord Minnett considers this a major positive, as the price increase could deliver incremental gross revenue of around $6m in FY19.
The company has also indicated price negotiations with Japanese customers will commence early in 2019. Ord Minnett assumes a favourable price outlook for FY20 as well, and upgrades FY19 and FY20 estimates by 12% and 8% respectively.
Buy rating maintained. Target rises to $4.27 from $3.91.
Target price is $4.27 Current Price is $3.33 Difference: $0.94
If MWY meets the Ord Minnett target it will return approximately 28% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY19:
Ord Minnett forecasts a full year FY19 dividend of 19.00 cents and EPS of 20.60 cents. |
Forecast for FY20:
Ord Minnett forecasts a full year FY20 dividend of 20.00 cents and EPS of 26.80 cents. |
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $17.36
UBS rates ORI as Reinstate Coverage with Buy (1) -
Despite the improvement in the global commodity cycle, UBS believes the Australian ammonium nitrate market is not in balance.
This situation is expected to prevail for the next few years because of the company's spare capacity at Yarwun and the ramp up of the Burrup facility in Western Australia.
Excess capacity is unlikely to be fully absorbed by the demand that is forecast through to FY22, constraining price inflation. Still, prices have largely bottomed in the broker's opinion.
UBS reinstates coverage with a Buy rating and $18.86 target.
Target price is $18.86 Current Price is $17.36 Difference: $1.5
If ORI meets the UBS target it will return approximately 9% (excluding dividends, fees and charges).
Current consensus price target is $17.73, suggesting upside of 2.1% (ex-dividends)
The company's fiscal year ends in September.
Forecast for FY19:
UBS forecasts a full year FY19 dividend of 51.00 cents and EPS of 93.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 93.4, implying annual growth of 9.0%. Current consensus DPS estimate is 53.8, implying a prospective dividend yield of 3.1%. Current consensus EPS estimate suggests the PER is 18.6. |
Forecast for FY20:
UBS forecasts a full year FY20 dividend of 63.00 cents and EPS of 113.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 106.8, implying annual growth of 14.3%. Current consensus DPS estimate is 62.9, implying a prospective dividend yield of 3.6%. Current consensus EPS estimate suggests the PER is 16.3. |
Market Sentiment: 0.1
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $76.16
Macquarie rates RIO as Outperform (1) -
The company has completed the sale of Dunkerque, which lifts total asset sales in 2018 to US$4.9bn. Rio Tinto is expected to return US$7.7bn in buybacks and US$8.6bn in dividends over the 18 months to June 2019.
Macquarie believes there is potential for additional cash should the sale of Grasberg proceeds as planned.
Macquarie maintains an Outperform rating and $94 target.
Target price is $94.00 Current Price is $76.16 Difference: $17.84
If RIO meets the Macquarie target it will return approximately 23% (excluding dividends, fees and charges).
Current consensus price target is $87.18, suggesting upside of 14.5% (ex-dividends)
The company's fiscal year ends in December.
Forecast for FY18:
Macquarie forecasts a full year FY18 dividend of 425.16 cents and EPS of 737.17 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 733.7, implying annual growth of N/A. Current consensus DPS estimate is 403.3, implying a prospective dividend yield of 5.3%. Current consensus EPS estimate suggests the PER is 10.4. |
Forecast for FY19:
Macquarie forecasts a full year FY19 dividend of 401.17 cents and EPS of 674.26 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 745.3, implying annual growth of 1.6%. Current consensus DPS estimate is 418.3, implying a prospective dividend yield of 5.5%. Current consensus EPS estimate suggests the PER is 10.2. |
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.6
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $0.56
UBS rates SIG as Upgrade to Neutral from Sell (3) -
Australian Pharmaceutical Industries ((API)) has accrued a 12.95% stake in Sigma and proposes to acquire the business via a scheme of arrangement.
The offer is 0.31 API shares and $0.23 cash per Sigma share. On balance, UBS suspects this latest merger deal could be successful, although there are a number of significant risks associated with ACCC acceptance.
The broker upgrades to Neutral from Sell and raises the target to $0.58 from $0.45.
Target price is $0.58 Current Price is $0.56 Difference: $0.02
If SIG meets the UBS target it will return approximately 4% (excluding dividends, fees and charges).
Current consensus price target is $0.50, suggesting downside of -10.3% (ex-dividends)
The company's fiscal year ends in January.
Forecast for FY19:
UBS forecasts a full year FY19 dividend of 5.00 cents and EPS of 4.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 4.1, implying annual growth of -26.8%. Current consensus DPS estimate is 3.8, implying a prospective dividend yield of 6.8%. Current consensus EPS estimate suggests the PER is 13.7. |
Forecast for FY20:
UBS forecasts a full year FY20 dividend of 3.00 cents and EPS of 3.00 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 2.4, implying annual growth of -41.5%. Current consensus DPS estimate is 2.1, implying a prospective dividend yield of 3.8%. Current consensus EPS estimate suggests the PER is 23.3. |
Market Sentiment: -0.5
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $0.24
Macquarie rates WAF as Outperform (1) -
The company has executed a US$200m funding package for Sanbrado and completed a $43.2m share placement. First gold is still expected in the third quarter of 2020 and an updated mine plan in the first quarter of 2019.
Completing the funding for Sanbrado is a de-risking event and Macquarie expects the company will accelerate development now. Drilling is likely to provide near-term catalysts, culminating in a resource/reserve upgrade early in 2019.
Outperform rating and $0.50 target maintained.
Target price is $0.50 Current Price is $0.24 Difference: $0.26
If WAF meets the Macquarie target it will return approximately 108% (excluding dividends, fees and charges).
The company's fiscal year ends in June.
Forecast for FY19:
Macquarie forecasts a full year FY19 dividend of 0.00 cents and EPS of minus 1.00 cents. |
Forecast for FY20:
Macquarie forecasts a full year FY20 dividend of 0.00 cents and EPS of minus 1.20 cents. |
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Overnight Price: $30.77
UBS rates WPL as Buy (1) -
Woodside is progressing with its development of the SNE field in Senegal. UBS currently values the phase 1 development for Woodside at $1.20 a share.
The broker is maintaining a watch on development expenditure, as a -10% reduction in capital expenditure would increase valuation by 8c a share.
The main catalysts are the final investment decision on Senegal in the second quarter of 2019 and Scarborough and Browse in 2020. UBS maintains a Buy rating and $40.70 target.
Target price is $40.70 Current Price is $30.77 Difference: $9.93
If WPL meets the UBS target it will return approximately 32% (excluding dividends, fees and charges).
Current consensus price target is $37.56, suggesting upside of 22.1% (ex-dividends)
The company's fiscal year ends in December.
Forecast for FY18:
UBS forecasts a full year FY18 dividend of 154.61 cents and EPS of 187.93 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 210.3, implying annual growth of N/A. Current consensus DPS estimate is 176.7, implying a prospective dividend yield of 5.7%. Current consensus EPS estimate suggests the PER is 14.6. |
Forecast for FY19:
UBS forecasts a full year FY19 dividend of 165.27 cents and EPS of 207.92 cents. How do these forecasts compare to market consensus projections? Current consensus EPS estimate is 270.2, implying annual growth of 28.5%. Current consensus DPS estimate is 220.9, implying a prospective dividend yield of 7.2%. Current consensus EPS estimate suggests the PER is 11.4. |
This company reports in USD. All estimates have been converted into AUD by FNArena at present FX values.
Market Sentiment: 0.4
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
Today's Price Target Changes
Company | Broker | New Target | Prev Target | Change | |
APA | APA | Credit Suisse | 7.65 | 11.00 | -30.45% |
CAR | CARSALES.COM | Ord Minnett | N/A | 14.84 | -100.00% |
IPL | INCITEC PIVOT | UBS | 3.70 | 4.00 | -7.50% |
KLL | KALIUM LAKES | Macquarie | 0.65 | 0.75 | -13.33% |
MWY | MIDWAY | Ord Minnett | 4.27 | 3.91 | 9.21% |
ORI | ORICA | UBS | 18.86 | 16.60 | 13.61% |
SIG | SIGMA HEALTHCARE | UBS | 0.58 | 0.45 | 28.89% |
Summaries
APA | APA | Downgrade to Underperform from Outperform - Credit Suisse | Overnight Price $8.70 |
ASB | AUSTAL | Accumulate - Ord Minnett | Overnight Price $1.95 |
BHP | BHP | Outperform - Macquarie | Overnight Price $33.57 |
Buy - UBS | Overnight Price $33.57 | ||
CAR | CARSALES.COM | No Rating - Ord Minnett | Overnight Price $11.55 |
FAR | FAR LTD | Outperform - Credit Suisse | Overnight Price $0.07 |
FMG | FORTESCUE | Outperform - Macquarie | Overnight Price $4.13 |
IPL | INCITEC PIVOT | Reinstate Coverage with Neutral - UBS | Overnight Price $3.44 |
KLL | KALIUM LAKES | Outperform - Macquarie | Overnight Price $0.33 |
MWY | MIDWAY | Buy - Ord Minnett | Overnight Price $3.33 |
ORI | ORICA | Reinstate Coverage with Buy - UBS | Overnight Price $17.36 |
RIO | RIO TINTO | Outperform - Macquarie | Overnight Price $76.16 |
SIG | SIGMA HEALTHCARE | Upgrade to Neutral from Sell - UBS | Overnight Price $0.56 |
WAF | WEST AFRICAN RESOURCES | Outperform - Macquarie | Overnight Price $0.24 |
WPL | WOODSIDE PETROLEUM | Buy - UBS | Overnight Price $30.77 |
RATING SUMMARY
Rating | No. Of Recommendations |
1. Buy | 10 |
2. Accumulate | 1 |
3. Hold | 2 |
5. Sell | 1 |
Tuesday 18 December 2018
Access Broker Call Report Archives here
Disclaimer:
The content of this information does in no way reflect the opinions of
FNArena, or of its journalists. In fact we don't have any opinion about
the stock market, its value, future direction or individual shares. FNArena solely reports about what the main experts in the market note, believe
and comment on. By doing so we believe we provide intelligent investors
with a valuable tool that helps them in making up their own minds, reading
market trends and getting a feel for what is happening beneath the surface.
This document is provided for informational purposes only. It does not
constitute an offer to sell or a solicitation to buy any security or other
financial instrument. FNArena employs very experienced journalists who
base their work on information believed to be reliable and accurate, though
no guarantee is given that the daily report is accurate or complete. Investors
should contact their personal adviser before making any investment decision.
Latest News
1 |
The Market In Numbers – 23 Nov 20249:09 AM - Australia |
2 |
ASX Winners And Losers Of Today – 22-11-24Nov 22 2024 - Daily Market Reports |
3 |
FNArena Corporate Results Monitor – 22-11-2024Nov 22 2024 - Australia |
4 |
Next Week At A Glance – 25-29 Nov 2024Nov 22 2024 - Weekly Reports |
5 |
Weekly Top Ten News Stories – 22 November 2024Nov 22 2024 - Weekly Reports |